Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Perinatol ; 27(12): 766-71, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17805339

ABSTRACT

OBJECTIVE: Bronchopulmonary dysplasia (BPD) in preterm infants is associated with impaired alveolar growth, inflammation and airway hyperreactivity. In animal models of BPD, inhaled nitric oxide (NO) improves alveolar growth and inhibits airway smooth muscle proliferation. This study was designed to assess the effect of inhaled NO on resistance and compliance in ventilated preterm infants with evolving BPD. STUDY DESIGN: Expiratory resistance and compliance of the respiratory system were measured in 71 ventilated preterm infants, < or = 32 weeks gestation, randomized to NO (n=34) versus placebo (n=37) for > or = 24 days at 7 to 21 days of life. RESULT: At baseline expiratory resistance (231+/-71 versus 215+/-76 cm H(2)O l(-1) s(-1)) and compliance (0.49+/-0.14 versus 0.53+/-0.13 ml cm H(2)O(-1) kg(-1)) were comparable between placebo and NO groups, respectively. There was no effect of NO on expiratory resistance or compliance at 1 h, 1 week or 2 weeks of study gas administration. CONCLUSION: NO had no short- or medium-term effect on expiratory resistance or compliance in ventilated preterm infants.


Subject(s)
Bronchodilator Agents/administration & dosage , Bronchopulmonary Dysplasia/drug therapy , Infant, Premature , Lung/drug effects , Lung/physiology , Nitric Oxide/administration & dosage , Administration, Inhalation , Airway Resistance/drug effects , Double-Blind Method , Exhalation/drug effects , Female , Humans , Infant, Low Birth Weight , Infant, Newborn , Lung Compliance/drug effects , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...